Idexx Laboratories (IDXX) Price & Analysis

Compare

2,120 Followers

IDXX Stock Chart & Stats

$712.47

$7.33(1.72%)

At close: Jan 08 4:00 PM EST

$712.47

$7.33(1.72%)

Day’s Range― - ―

52-Week Range$356.14 - $735.00

Previous CloseN/A

Volume277.29K

Average Volume (3M)505.51K

Market Cap

$56.66B

Enterprise Value$52.45B

Total Cash (Recent Filing)$208.17M

Total Debt (Recent Filing)$1.11B

Price to Earnings (P/E)56.5

Beta0.96

Next Earnings

Feb 09, 2026

EPS Estimate

2.93

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)3.40

Shares Outstanding79,851,330

10 Day Avg. Volume701,429

30 Day Avg. Volume505,515

Financial Highlights & Ratios

PEG Ratio6.51

Price to Book (P/B)21.37

Price to Sales (P/S)8.75

P/FCF Ratio42.72

Enterprise Value/Market Cap0.93

Enterprise Value/Revenue12.59

Enterprise Value/Gross Profit20.39

Enterprise Value/Ebitda36.12

Forecast

1Y Price Target

$785.56

Price Target Upside10.26% Upside

Rating ConsensusModerate Buy

Number of Analyst Covering10

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Innovations And Product LaunchesInnovations like inVue Dx and Cancer Dx should support more than 150 basis points of incremental organic growth for Idexx’s Companion Animal Group.

International ExpansionCancer Dx is gaining traction with a strong presence in North America and plans for international expansion.

Recurring Revenue GrowthIDXX raised its guidance to reflect strength in CAG recurring revenues and inVue.

Bears Say

Decline In Vet VisitsUS vet visits have declined every quarter since 2022, posing a pressure point for IDEXX.

Revenue Growth ProjectionsRevenue growth projections are below consensus, reflecting a conservative outlook amid macro uncertainties.

Valuation ConcernsDespite strong performance, the valuation of IDXX is considered to have appropriately priced in this strength, leading to a reiteration of a Neutral rating.

Idexx Laboratories News

Idexx Laboratories price target raised to $775 from $700 at Piper Sandler

Piper Sandler raised the firm’s price target on Idexx Laboratories (IDXX) to $775 from $700 following quarterly results....

3d ago

IDXX

Idexx Laboratories price target raised to $805 from $765 at Morgan Stanley

Morgan Stanley raised the firm’s price target on Idexx Laboratories (IDXX) to $805 from $765 and keeps an...

9d ago

IDXX

Idexx Laboratories price target raised to $750 from $710 at UBS

UBS raised the firm’s price target on Idexx Laboratories (IDXX) to $750 from $710 and keeps a Neutral...

9d ago

IDXX

Idexx Laboratories price target raised to $830 from $785 at BTIG

BTIG raised the firm’s price target on Idexx Laboratories (IDXX) to $830 from $785 and keeps a Buy...

9d ago

IDXX

Idexx Laboratories price target raised to $790 from $700 at BofA

BofA raised the firm’s price target on Idexx Laboratories (IDXX) to $790 from $700 and keeps a Neutral...

10d ago

IDXX

Idexx Laboratories price target raised to $785 from $745 at Leerink

Leerink raised the firm’s price target on Idexx Laboratories (IDXX) to $785 from $745 and keeps an Outperform...

10d ago

IDXX

Idexx Laboratories price target raised to $775 from $700 at Stifel

Stifel analyst Jonathan Block raised the firm’s price target on Idexx Laboratories (IDXX) to $775 from $700 and...

10d ago

IDXX

Early notable gainers among liquid option names on November 3rd

Notable gainers among liquid option names this morning include Kenvue Inc (KVUE) $16.81 +2.44, IDEXX (IDXX) $715.48 +85.97,...

10d ago

AMZN

Idexx Laboratories reports Q3 EPS $3.40, consensus $3.14

Reports Q3 revenue $1.105, consensus $1.07B. “IDEXX made exceptional progress on our innovation-driven growth strategy with strong execution...

10d ago

IDXX

Idexx Laboratories raises FY25 EPS view to $12.81-$13.01 from $12.40-$12.76

Raises FY25 revenue view to $4.270B-$4.300B from $4.205B-$4.280B. Consensus is for FY25 EPS $12.63 and for revenue $4.23B....

10d ago

IDXX

These Are the Stocks Reporting Earnings Today – November 3, 2025

Here’s a look at today’s key earnings reports from major publicly traded companies. Stock market investors will undoubtedly...

10d ago

IDEXX Laboratories Reports Strong Q3 Earnings and Raises Guidance

Idexx Laboratories (($IDXX)) has held its Q3 earnings call. Read on for the main highlights of the call....

9d ago

IDXX

Idexx Laboratories: Strong Financial Performance and Strategic Advancements Justify Buy Rating

Mark Massaro, an analyst from BTIG, reiterated the Buy rating on Idexx Laboratories. The associated price target was...

9d ago

IDXX

IDEXX Laboratories Reports Strong Q3 2025 Results

Idexx Laboratories ( ($IDXX) ) has released its Q3 earnings. Here is a breakdown of the information Idexx...

9d ago

IDXX

IDXX FAQ

What was Idexx Laboratories’s price range in the past 12 months?

Idexx Laboratories lowest stock price was $356.14 and its highest was $735.00 in the past 12 months.

What is Idexx Laboratories’s market cap?

Idexx Laboratories’s market cap is $56.66B.

When is Idexx Laboratories’s upcoming earnings report date?

Idexx Laboratories’s upcoming earnings report date is Feb 09, 2026 which is in 88 days.

How were Idexx Laboratories’s earnings last quarter?

Idexx Laboratories released its earnings results on Nov 03, 2025. The company reported $3.4 earnings per share for the quarter, beating the consensus estimate of $3.138 by $0.262.

Is Idexx Laboratories overvalued?

According to Wall Street analysts Idexx Laboratories’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Idexx Laboratories pay dividends?

Idexx Laboratories does not currently pay dividends.

What is Idexx Laboratories’s EPS estimate?

Idexx Laboratories’s EPS estimate is 2.93.

How many shares outstanding does Idexx Laboratories have?

Idexx Laboratories has 79,851,330 shares outstanding.

What happened to Idexx Laboratories’s price movement after its last earnings report?

Idexx Laboratories reported an EPS of $3.4 in its last earnings report, beating expectations of $3.138. Following the earnings report the stock price went up 14.842%.

Which hedge fund is a major shareholder of Idexx Laboratories?

Currently, no hedge funds are holding shares in IDXX

Idexx Laboratories Stock Smart Score

Outperform

Fundamentals

Return on Equity

64.63%

Trailing 12-Months

Asset Growth

1.07%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Idexx Laboratories

IDEXX Laboratories, Inc. is a global leader in veterinary diagnostics, water testing, and dairy and food safety. Founded in 1983 and headquartered in Westbrook, Maine, IDEXX primarily serves the veterinary market with innovative products and services that enhance the health and well-being of pets. The company operates in several segments, including Companion Animal Group, Livestock, Poultry, and Dairy, as well as Water and Food Testing. Its core products include diagnostic tests, instruments, and software solutions that facilitate rapid and accurate disease diagnosis and management.

Idexx Laboratories (IDXX) Earnings & Revenues

Historic Earnings Reports

IDXX Company Deck

IDXX Earnings Call

Q3 2025

0:00 / 0:00

Earnings Call Sentiment|Positive

IDEXX Laboratories reported strong financial performance and increased its full year guidance, driven by gains in CAG Diagnostics and international markets. However, challenges such as a decline in U.S. clinical visits and wellness visits persisted, along with impacts from foreign exchange and rapid assay revenue shifts.View all IDXX earnings summaries

IDXX Revenue Breakdown

91.70% CAG

4.75% Water

3.13% LPD

0.42% Other

IDXX Stock 12 Month Forecast

Average Price Target

$785.56

▲(10.26% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"412":"$412","831":"$831","516.75":"$516.8","621.5":"$621.5","726.25":"$726.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":830,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$830.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":785.56,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$785.56</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":750,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$750.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[412,516.75,621.5,726.25,831],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jan<br/>2025","6":"Apr<br/>2025","9":"Jul<br/>2025","12":"Nov<br/>2025","25":"Nov<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,629.51,644.9323076923076,660.3546153846154,675.776923076923,691.1992307692308,706.6215384615384,722.0438461538462,737.4661538461538,752.8884615384616,768.3107692307692,783.733076923077,799.1553846153846,814.5776923076924,{"y":830,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,629.51,641.5138461538461,653.5176923076923,665.5215384615384,677.5253846153846,689.5292307692307,701.5330769230769,713.536923076923,725.5407692307692,737.5446153846153,749.5484615384615,761.5523076923076,773.5561538461538,{"y":785.56,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,629.51,638.7784615384616,648.0469230769231,657.3153846153846,666.5838461538461,675.8523076923077,685.1207692307693,694.3892307692307,703.6576923076923,712.9261538461539,722.1946153846154,731.4630769230769,740.7315384615384,{"y":750,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":495.42,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":417.28,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":430.77,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":413.44,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":422.05,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":437.11,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":418.57,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":471.38,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":514.8,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":542.65,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":535.54,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":620.11,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":629.51,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >